GSK Reaches Confidential Settlement in Zantac Cancer Lawsuit
GSK Stock Price Boosted by Amicable Settlement in Zantac Cancer Lawsuit British pharmaceutical giant GSK experienced a significant boost in its stock price on Friday morning following the announcement of an amicable settlement in a California lawsuit related to its heartburn drug, Zantac. The drug has been accused by patients of contributing to their cancer. … Read more